An investigator-initiated phase I study of crizotinib in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) before or after progression on docetaxel Meeting Abstract
| Authors: | Harshman, L. C.; Gray, K. P.; Polacek, L.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M. M.; Bellmunt, J.; Yu, C.; Sun, Z.; Srinivas, S.; Kantoff, P. W.; Sweeney, C. |
| Abstract Title: | An investigator-initiated phase I study of crizotinib in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) before or after progression on docetaxel |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Language: | English |
| ACCESSION: | WOS:000404711501078 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.e16509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e16509 -- Source: Wos |
